Key result
Bromocriptine blunted plasma norepinephrine, renin activity, and aldosterone responses to lower body negative pressure and tilting, and induced hypotension with increased potassium and AVP.
Why the study?
Does bromocriptine alter the hormonal and hemodynamic responses to lower body negative pressure and tilting in normal humans?
Does bromocriptine alter the hormonal and hemodynamic responses to lower body negative pressure and tilting in normal humans?
Bromocriptine blunts sympathetic and renin-angiotensin-aldosterone responses to orthostatic stress, leading to hypotension and compensatory increases in vasopressin and potassium.
Answers are grounded in this paper and cite their sources.
Bromocriptine effects warrant caution during orthostasis; leaves open clinical relevance in patients with autonomic or volume disorders.
We have examined the effects of the dopamine agonist bromocriptine (BEC) on the hormonal and hemodynamic response to graded lower body negative pressure (LBNP) and tilting in five normal volunteers. BEC blunted the plasma norepinephrine (NE), plasma renin activity (PRA), and aldosterone responses to both LBNP and tilting. The inhibitory effects of BEC on the plasma NE response to these maneuvers are likely mediated through presynaptic inhibition of peripheral neuronal release of NE as well as central nervous system effects of the drug. Since the PRA responses to LBNP and tilting are likely mediated through beta-adrenoreceptor stimulation, BEC probably indirectly blunts the PRA and aldosterone responses to those maneuvers through its inhibitory effects on NE secretion. BEC treatment resulted in a hypotensive response to tilting that was accompanied by a rise in plasma potassium and arginine vasopressin (AVP). No such rises in plasma potassium and AVP are observed, in the absence of BEC treatment, following graded LBNP and tilting. The rise in plasma potassium with tilting (BEC treatment) probably resulted from blunting of the NE rise. Thus, the rise in plasma NE may play an important role in preventing a rise in plasma potassium in association with LBNP and orthostatic stress. AVP levels in normal men are not responsive to unloading of cardiopulmonary and sinoaortic baroreceptors. It is only after overt hypotension is produced--as after BEC treatment--that plasma levels of AVP rise.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (1985) studied Normal volunteers (n=5). Bromocriptine vs. Absence of bromocriptine treatment was evaluated on Hormonal and hemodynamic response to graded lower body negative pressure and tilting. Bromocriptine blunted plasma norepinephrine, renin activity, and aldosterone responses to lower body negative pressure and tilting, and induced hypotension with increased potassium and AVP.
Synapse has enriched 10 related papers. Consider them for comparative context: